Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
| Metric | BBIO | INCY |
|---|---|---|
| Price | $65.90 | $118.78 |
| Change today | ▲ 0.15% | ▼ 2.12% |
| Market cap | $12.88B | $24.08B |
| Return, 3 months | – | +4.4% |
| Return, year to date | – | +20.3% |
| Return, 1 year | – | +37.0% |
| P/E (TTM) | -18.5 | 15.1 |
| P/B | -5.1 | 3.8 |
| P/E percentile vs own 5y | – | 7th |
| Dividend yield | – | – |
| Revenue growth (YoY, latest qtr) | – | +37.7% |
| Net profit growth (YoY) | – | +44.6% |
| Gross margin | – | 92.6% |
| Operating margin | – | 31.6% |
| Net margin | – | 27.7% |
| Return on equity | – | 30.7% |
| Analyst target vs. price | +69.1% | +18.4% |
| Analyst buy share | 94% | 79% |
| RSI (14) | – | 44 |
| 30-day volatility | – | 26.3% |
| Max drawdown, 1 year | – | -18.3% |
| Trend read | – | Leaning bearish |
| Analyst consensus | Buy | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
